With the market rallying sharply yesterday, and our Danish biotech play rallying 1.9%, you enjoyed partial recovery in the value of your $120 June Novo Nordisk call options (NVO110618C00120000).
Because “implied volatility” is such a big component in the value of these options, I am recommending that you sell your options here.
Now, it’s going to be at a loss compared to your buy price way back on Feb. 16. But yesterday’s sharp jump does allow you to salvage some more value before the options expire this Friday, June 17.
Hold on to the stock for now, as NovoNordisk (NVO) has proven to be one of our better defensive plays in the market downturn.
This content is for paid subscribers only. To gain access subscribe to one of our…
It is hard to find a seasoned investor who doesn’t believe the stock market is…
No one believes a financial disaster can strike… until it’s too late. That’s bizarre, considering…
The Options Industry Council is a resource used to educate investors about the benefits and…
The put-call parity is the relationship that exists between put and call prices of the…
“It’s not a stock market, it’s a market of stocks.” -- “Maxims of Wall Street,”…